Phases of Mesothelioma Clinical Trials
Mesothelioma clinical trials are normally done in three phases:
1) Phase I trial: This trial involves only very few people. It is used to test the effectiveness of the new drugs or new type of treatment.
2) Phase II trial: This trial involves a larger group of subjects. The drug’s side effects, safety, dosage and effectiveness are tested using this trial.
3) Phase III trial: This trial involves a huge amount of people from various cancer treatment Centers simultaneously. This is a comparative trial in which the new medicine or type of treatment is compared to the existing ones. The comparative risks, benefits and effectiveness are analyzed.
Benefits of mesothelioma clinical trials
There are many benefits of taking part in a mesothelioma clinical trial. Some of these benefits are listed below:
1) The patients who participate in mesothelioma clinical trials have easy access to the latest drugs and treatments that have been invented. These are not available for the other non-participants.
2) Normally, the new drugs and treatments are invented after much research and experiments. So, they are more effective and work well than the current drugs and treatments. So, the volunteers would highly benefit from these new drugs and treatments.
3) The medical research personnel and doctors consider a participant in a mesothelioma clinical trial a very special person. So, the volunteer gets lots of special and close medical attention on all aspects of the treatment.
4) Every clinical trial helps medical science advance one more step. This will define the medicines and treatments of the future. The destiny of millions depends on these advancements.
5) The volunteers for mesothelioma clinical trials are contributing to a huge social cause. It is because of them that many find their life during the disease more comfortable.
The above are the various benefits for volunteers taking part in mesothelioma clinical trials.
Risks involved in participating in a mesothelioma clinical trial
A mesothelioma clinical trial is only an experimental study of new drugs and new types of treatments. These may be advantageous or disadvantageous. The main risks associated with taking part in a mesothelioma clinical trial are as follows:
1) The new medicine or new method of treatment may not be better than the current one. Sometimes, it may even worsen the condition.
2) Mostly, medical researchers and doctors are not aware of the exact side effects and consequences of the new medicines or types of treatment invented by them. So, there may also arise to be risky side effects because of the clinical trial.
3) The clinical trial treatments may not be covered by health insurance. So,
It is always better to find out about this before going in for the mesothelioma clinical trial.
4) A clinical trial involves much more interaction between the doctor and the patient. So, the patient will have to go to the hospital more often. These frequent visits may be tiresome and irritating during an uncomfortable illness like mesothelioma.
5) If the patient gives a complete free hand to the doctors and researchers, then they may not have any choice in the treatment, which they will receive. This may be difficult and risky for the patient.
To read the full article, click Analyzing Mesothelioma Clinical Trials
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment